Tizanidine
Product Images NDC 58517-380

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 58517-380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by New Horizon Rx Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4ed0bea5-figure-01 (4ed0bea5 Figure 01)

Chemical structure of Tizanidine hydrochloride, displaying its molecular components with chlorine, nitrogen, sulfur atoms, and the hydrochloride moiety.*

FDA Label Image

4ed0bea5-figure-02 (4ed0bea5 Figure 02)

A line graph depicting plasma Tizanidine concentration (ng/mL) over 24 hours after dosing. It compares four conditions: 2 x 4 mg Tizanidine tablets with food, without food, and 2 x 4 mg Tizanidine capsules with food and without food. The y-axis shows plasma concentration in ng/mL and the x-axis shows time in hours post dosing.*

FDA Label Image

4ed0bea5-figure-03 (4ed0bea5 Figure 03)

A line graph showing improvement in Ashworth Score over 6 hours post-dose for three groups: placebo, 8 mg tizanidine, and 16 mg tizanidine. The vertical axis represents improvement scores, while the horizontal axis shows time in hours after dosing. The graph includes error bars for each time point and treatment group.*

FDA Label Image

4ed0bea5-figure-04 (4ed0bea5 Figure 04)

A chart showing mean Ashworth Score improvement over time comparing Tizanidine (mean dose 28.8 mg) to placebo. The x-axis labels indicate End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). Vertical error bars represent variability at each point for both Tizanidine and placebo groups.*

FDA Label Image

4ed0bea5-figure-05 (4ed0bea5 Figure 05)

Tizanidine Tablets USP 4 mg label from New Horizon Rx Group, LLC. The label states 30 tablets per container and includes a warning that Tizanidine Tablets are not interchangeable with Tizanidine Capsules. It also provides dosage strength, storage instructions, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.